Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2005
09/29/2005WO2005090312A1 5-aminoalkylpyrazole derivatives as pesticidal agents
09/29/2005WO2005090305A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005WO2005090300A1 Novel benzyl(idene)-lactam derivatives
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090294A2 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES
09/29/2005WO2005089770A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005WO2005089754A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/29/2005WO2005089747A1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
09/29/2005WO2005089716A1 Preparation with elevated content
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2005089551A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
09/29/2005WO2005065183A3 Mitotic kinesin inhibitors
09/29/2005WO2005058844A3 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
09/29/2005WO2005051917A9 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
09/29/2005WO2004105752A8 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
09/29/2005US20050215784 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/29/2005US20050215783 Thiourea compositions and uses thereof
09/29/2005US20050215616 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol; treating vaginal and skin atrophy
09/29/2005US20050215614 Substituted indoles and their use as hcv inhibitors
09/29/2005US20050215610 Such as 3-(4-(2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoylamino)-imidazol-1-yl)-butyric acid methyl ester; secretase, A beta -peptide inhibitor; neurogenerative and neurological diseases: Alzheimer's disease; Notch signaling pathway inhibitor; antiinflammatory agent, asthma, autoimmune diseases
09/29/2005US20050215599 Pyrrolidine-3,4-dicarboxamide derivatives
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215577 Tetrahydrocarbazoles and derivatives
09/29/2005US20050215574 4-anilino quinazoline derivatives as antiproliferative agents
09/29/2005US20050215573 Novel inhibitors of glutaminyl cyclase
09/29/2005US20050215559 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
09/29/2005US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215526 Melanin concentrating hormone receptor antagonist
09/29/2005US20050214539 Porous carbon structures and methods
09/29/2005DE102004012070A1 Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New cycloalkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005DE102004012069A1 Neue aryl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New aryl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005DE102004012068A1 Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New alkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005DE102004011705A1 Substituierte 4-(4-Trifluormethylpyrazolyl)-Pyrimidine Substituted 4- (4-Trifluormethylpyrazolyl) -pyrimidines
09/29/2005DE102004001873A1 Cyanopyrimidinone Cyanopyrimidinone
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/29/2005CA2560298A1 Preparation with elevated content
09/29/2005CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005CA2560199A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2559097A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
09/29/2005CA2558058A1 N-piperidine derivates as ccr3 modulators
09/29/2005CA2557929A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005CA2557054A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/28/2005EP1578755A1 Phosphonooxy quinazoline derivatives and their pharmaceutical use
09/28/2005EP1578732A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/28/2005EP1578731A2 Process for the preparation of pyrimidine compounds
09/28/2005EP1578413A2 Ace-inhibitors having antioxidant and no-donor activity
09/28/2005EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
09/28/2005EP1286987B1 Heterocyclic hydrazones for use as anti-cancer agents
09/28/2005EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/28/2005EP1132387B1 Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultural/horticultural fungicides
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1674899A Use of IkappaB-kinase inhibitors in pain therapy
09/28/2005CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
09/28/2005CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/28/2005CN1674892A Hetero biaryl derivatives as matrix metalloproteinase inhibitors
09/28/2005CN1220695C Inhibitors of nucleoside metabolism
09/28/2005CN1220684C 2, 4, Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220681C Indole derivatives as XA factor inhibitors
09/27/2005US6949642 Production of tertiary amines by reductive amination
09/27/2005US6949630 acridine, anthraquinone, azine, azo, azomethine, dioxazine, methine, oxazine and imidazole hair dyes
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949577 Drugs such as 5-amino-2-((1-n-propyl-1H-imidazol-4-yl)methyl) pentanoic acid, used as carboxypeptidase inhibitors for prophylaxis of thrombosis, atherosclerosis, adhesions, cancer, scarring, fibrosis and inflammation; bradykinins
09/27/2005US6949572 Antilipemic or antilipolytic agents for treatment of obesity and lipid disorders, S)-N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide
09/27/2005US6949570 Carboxyalkyl substituted sulfonamidomethyl amides or ureas used for treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, and diabetes
09/27/2005US6949564 NPY-5 antagonists
09/27/2005US6949562 Heterocyclic compounds as ligands of the GABAA receptor
09/27/2005US6949550 Substituted amino methyl factor Xa inhibitors
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949542 Dihydro-benzo[b][1,4]diazepin-2-one derivatives
09/27/2005US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005087784A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule
09/22/2005WO2005087764A1 Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents)
09/22/2005WO2005087762A1 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug each comprising the same
09/22/2005WO2005087761A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087751A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087748A1 Ion channel modulators
09/22/2005WO2005087747A1 Ion channel modulators
09/22/2005WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
09/22/2005WO2005087727A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087726A1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
09/22/2005WO2005087724A2 Sulphonylpyrroles as hdac inhibitors
09/22/2005WO2005087722A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087721A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087237A1 Fasudil-containing preparation and method of improving stability thereof
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087229A1 Ion channel modulators
09/22/2005WO2005087228A1 Ion channel modulators
1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 626